Skip to main content
. 2021 Aug 11;16(1):1143–1149. doi: 10.1515/med-2021-0322

Table A1.

parameters in active tuberculosis and community-acquired pneumonia and healthy control (Mean ± SD)

Parameter 1 2 3 P
ATB (N = 88) CAP (N = 78) HC (N = 89) 1 vs 2 1 vs 3 2 vs 3
WBC 6.614 ± 2.224 8.175 ± 4.097 7.086 ± 2.746 0.0208 Ns Ns
NE% 64.18 ± 9.191 71.31 ± 13.1 68.74 ± 12.46 <0.0001 0.0075 Ns
LY% 20.7 ± 8.047 18.04 ± 13.6 21.23 ± 10.25 0.0302 Ns 0.0348
MO% 9.899 ± 3.522 7.945 ± 2.992 7.466 ± 2.579 <0.0001 <0.0001 Ns
neutrophil CPD parameter
NMV 144.2 ± 6.266 145.2 ± 7.995 145.7 ± 7.233 Ns Ns Ns
NMV-SD 20.32 ± 3.177 18.81 ± 2.633 17.85 ± 2.107 0.0059 <0.0001 Ns
NMC 153.4 ± 2.645 139.8 ± 7.314 151.5 ± 3.526 <0.0001 0.0003 <0.0001
NMC-SD 9.042 ± 3.948 5.863 ± 1.734 5.536 ± 1.051 <0.0001 <0.0001 Ns
N-MALS 134.3 ± 5.684 128.99.347 136.6 ± 4.945 0.0006` 0.0262 <0.0001
N-MALS-SD 14.95 ± 5.118 12.73 ± 2.612 11.05 ± 1.572 0.0305 <0.0001 <0.0001
N-UMALS 137.8 ± 4.474 124.2 ± 11.22 136.3 ± 5.342 <0.0001 Ns <0.0001
N-UMALS-SD 14.5 ± 4.385 16.82 ± 6.577 11.85 ± 1.68 Ns <0.0001 <0.0001
N-LMALS 126.8 ± 9.128 127.3 ± 11.23 133 ± 6.441 Ns <0.0001 0.0016
N-LMALS-SD 19.16 ± 6.887 16.26 ± 4.386 14.05 ± 2.624 0.0008 <0.0001 0.0004
N-LALS 155.2 ± 20.28 163.6 ± 18 170.9 ± 13.64 0.011 <0.0001 Ns
N-LALS-SD 41.1 ± 6.712 34.27 ± 7.237 33.03 ± 6.652 <0.0001 <0.0001 Ns
N-AL2 142.8 ± 3.893 140.7 ± 4.248 140.7 ± 5.399 0.0023 0.0048 Ns
N-AL2-SD 15.72 ± 4.343 15.73 ± 3.459 11.56 ± 1.843 Ns <0.0001 <0.0001
lymphocyte CPD parameter
LMV 89.19 ± 4.457 89.1 ± 4.323 87.49 ± 3.956 Ns 0.0409 Ns
LMV-SD 17.55 ± 3.883 15.38 ± 2.686 15.31 ± 2.534 0.0011 <0.0001 Ns
LMC 119.6 ± 3.204 111.7 ± 6.74 120.4 ± 3.021 <0.0001 Ns <0.0001
LMC-SD 13.09 ± 2.558 9.642 ± 3.156 9.136 ± 1.923 <0.0001 <0.0001 Ns
L-MALS 61.27 ± 6.314 51.29 ± 13.23 64.53 ± 7.477 <0.0001 0.0029 <0.0001
L-MALS-SD 19.65 ± 2.614 17.42 ± 1.702 17.59 ± 1.808 <0.0001 <0.0001 Ns
L-UMALS 64.13 ± 8.007 44.54 ± 20.61 66 ± 9.197 <0.0001 Ns <0.0001
L-UMALS-SD 21.91 ± 2.516 19.99 ± 2.875 19.41 ± 1.508 <0.0001 <0.0001 Ns
L-LMALS 54.03 ± 5.828 51.71 ± 7.47 58.43 ± 6.191 Ns <0.0001 <0.0001
L-LMALS-SD 21.67 ± 2.818 20.19 ± 1.55 20.36 ± 1.664 <0.0001 <0.0001 Ns
L-LALS 39.85 ± 4.814 38.87 ± 2.894 37.65 ± 2.692 Ns <0.0001 0.0207
L-LALS-SD 14.94 ± 4.987 12.38 ± 1.96 11.69 ± 1.637 <0.0001 <0.0001 Ns
L-AL2 75.76 ± 3.785 79.28 ± 3.407 75.23 ± 2.807 <0.0001 Ns <0.0001
L-AL2-SD 12.78 ± 3.313 11.91 ± 2.354 10.94 ± 1.366 0.0223 <0.0001 0.0195
monocyte CPD parameter
MMV 182.4 ± 11.35 166 ± 10.34 166.8 ± 7.935 <0.0001 <0.0001 Ns
MMV-SD 21.96 ± 2.533 20.51 ± 3.783 18.95 ± 3.034 0.0004 <0.0001 0.0108
MMC 132.5 ± 2.389 119.4 ± 6.561 128.9 ± 3.146 <0.0001 <0.0001 <0.0001
MMC-SD 7.266 ± 3.161 6.811 ± 2.953 6.087 ± 1.876 0.0216 <0.0001 Ns
M-MALS 84.27 ± 3.353 74.19 ± 12.72 86.59 ± 5.088 0.0002 0.0002 <0.0001
M-MALS-SD 10.91 ± 1.396 13.31 ± 2.944 11.74 ± 1.295 <0.0001 <0.0001 0.0012
M-UMALS 94.48 ± 5.368 76.29 ± 18.02 94.69 ± 6.135 <0.0001 Ns <0.0001
M-UMALS-SD 11.87 ± 1.99 16.48 ± 4.544 12.73 ± 1.858 <0.0001 0.0015 <0.0001
M-LMALS 71.01 ± 2.845 67.46 ± 9.699 75.58 ± 5.032 Ns <0.0001 <0.0001
M-LMALS-SD 14.07 ± 3.399 16.77 ± 3.094 14.73 ± 1.617 <0.0001 0.0001 <0.0001
M-LALS 81.4 ± 11.04 87.42 ± 14.32 90.58 ± 12.19 0.0001 <0.0001 Ns
M-LALS-SD 23.19 ± 4.195 25.94 ± 3.796 26.43 ± 3.898 <0.0001 <0.0001 Ns
M-AL2 131.6 ± 5.154 134.2 ± 4.587 131.3 ± 4.686 0.0003 Ns 0.0001
M-AL2-SD 12.45 ± 2.246 14.71 ± 3.824 12.64 ± 2.588 <0.0001 Ns <0.0001

ATB: Active Tuberculosis, CAP: Community-acquired pneumonia, HC: Health control, WBC: White blood count, NE%: neutrophil percentage, LY%: lymphocyte percentage, MO%: monocyte percentage, NMV: Neutrophil mean volume,NMV-SD: Neutrophil mean volume standard deviation, NMC: Neutrophil mean conductivity, NMC-SD: Neutrophil mean conductivity standard deviation, N-MALS: Neutrophil medium angle light scatter, N-MALS-SD: Neutrophil medium angle light scatter standard deviation: N-UMALS: Neutrophil upper medium angle light scatter, N-UMALS-SD: Neutrophil upper medium angle light scatter standard deviation, N-LMALS: Neutrophil lower medium angle light scatter, N-LMALS-SD: Neutrophil lower medium angle light scatter standard deviation, N-LALS: Neutrophil lower angle light scatter, N-LALS-SD: Neutrophil lower angle light scatter standard deviation, N-AL2: Neutrophil axial light loss measurement, N-AL2-SD: Neutrophil axial light loss measurement standard deviation, LMV: Lymphocyte mean volume, LMV-SD: Lymphocyte mean volume standard deviation, LMC: Lymphocyte mean conductivity,LMC-SD: Lymphocyte mean conductivity standard deviation, L-UMALS:Lymphocyte upper median angle light scatter, L-UMALS-SD: Lymphocyte upper median angle light scatter standard deviation, L-MALS: Lymphocyte medium angle light scatter, L-MALS-SD: Lymphocyte medium angle light scatter standard deviation, L-LMALS: Lymphocyte lower median angle light scatter, L-LMALS-SD: Lymphocyte lower median angle light scatter standard deviation, L-LALS: Lymphocyte lower angle light scatter, L-LALS-SD: Lymphocyte lower angle light scatter standard deviation, L-AL2: Lymphocyte axial light loss measurement, L-AL2-SD: Lymphocyte axial light loss measurement standard deviation, MMV: Monocyte mean volume, MMV-SD: Monocyte mean volume standard deviation, MMC: Monocyte mean conductivity, MMC-SD: Monocyte mean conductivity standard deviation, M-UMALS: Monocyte upper median angle light scatter, M-UMALS-SD: Monocyte upper median angle light scatter standard deviation, M-MALS: Monocyte medium angle light scatter, M-MALS-SD: Monocyte medium angle light scatter standard deviation, M-LMALS: Monocyte lower median angle light scatter, M-LMALS-SD: Monocyte lower median angle light scatter standard deviation, M-LALS: Monocyte lower angle light scatter, M-LALS-SD: Monocyte lower angle light scatter standard deviation, M-AL2: Monocyte axial light loss measurement, M-AL2-SD: Monocyte axial light loss measurement standard deviation.